Millenco sells 353,343 shares of Orchid Cellmark, cutting stake to 4.6%

By Susanna Moon

Chicago, Oct. 7 - Orchid Cellmark Inc. investor Millenco LLC sold 353,343 shares of the company's stock, according to a schedule 13D filing with the Securities and Exchange Commission.

The investor now owns 1,371,342 shares, or 4.6%, of the company's common stock.

Millenco sold 3,343 shares at $2.80 each on Sept. 19 and sold 350,000 shares at $2.35 apiece on Oct. 3.

On Oct. 3, the investor ceased to beneficially own more than 5% of the issuer's common stock.

Orchid Cellmark, located in Princeton, N.J., provides DNA testing services for the human identity and agricultural sectors.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.